Cargando…

The Association of Combined GSTM1 and CYP2C9 Genotype Status with the Occurrence of Hemorrhagic Cystitis in Pediatric Patients Receiving Myeloablative Conditioning Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation

Hemorrhagic cystitis (HC) is one of the complications of busulfan-cyclophosphamide (BU-CY) conditioning regimen during allogeneic hematopoietic stem cell transplantation (HSCT) in children. Identifying children at high risk of developing HC in a HSCT setting could facilitate the evaluation and imple...

Descripción completa

Detalles Bibliográficos
Autores principales:	Uppugunduri, Chakradhara Rao S., Storelli, Flavia, Mlakar, Vid, Huezo-Diaz Curtis, Patricia, Rezgui, Aziz, Théorêt, Yves, Marino, Denis, Doffey-Lazeyras, Fabienne, Chalandon, Yves, Bader, Peter, Daali, Youssef, Bittencourt, Henrique, Krajinovic, Maja, Ansari, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504863/ https://www.ncbi.nlm.nih.gov/pubmed/28744217 http://dx.doi.org/10.3389/fphar.2017.00451

Ejemplares similares

GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation
por: Jurkovic Mlakar, Simona, et al.
Publicado: (2021)

Correction to: GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation
por: Jurkovic Mlakar, Simona, et al.
Publicado: (2021)

Pharmacogenomics in Pediatric Oncology: Review of Gene—Drug Associations for Clinical Use †
por: Mlakar, Vid, et al.
Publicado: (2016)

GSTA1 diplotypes affect busulfan clearance and toxicity in children undergoing allogeneic hematopoietic stem cell transplantation: a multicenter study
por: Ansari, Marc, et al.
Publicado: (2017)

Association study of candidate DNA-repair gene variants and acute graft versus host disease in pediatric patients receiving allogeneic hematopoietic stem-cell transplantation
por: Uppugunduri, C. R. S., et al.
Publicado: (2021)

Precision dosing of intravenous busulfan in pediatric hematopoietic stem cell transplantation: Results from a multicenter population pharmacokinetic study
por: Ben Hassine, Khalil, et al.
Publicado: (2021)

Association of CTH variant with sinusoidal obstruction syndrome in children receiving intravenous busulfan and cyclophosphamide before hematopoietic stem cell transplantation
por: Huezo-Diaz Curtis, P, et al.
Publicado: (2018)

A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation
por: Robin, Shannon, et al.
Publicado: (2022)

Correction to: A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation
por: Robin, Shannon, et al.
Publicado: (2022)

The Clinical Relevance of Pre-Formed Anti-HLA and Anti-MICA Antibodies after Cord Blood Transplantation in Children
por: Ansari, Marc, et al.
Publicado: (2013)

Influence of glutathione S-transferase gene polymorphisms on busulfan pharmacokinetics and outcome of hematopoietic stem-cell transplantation in thalassemia pediatric patients
por: Ansari, M, et al.
Publicado: (2016)

Physiologically‐Based Pharmacokinetic Modeling for the Prediction of CYP2D6‐Mediated Gene–Drug–Drug Interactions
por: Storelli, Flavia, et al.
Publicado: (2019)

Development and validation of an allele-specific PCR assay for genotyping a promoter and exonic single nucleotide polymorphisms of MGMT gene
por: Tyagi, Anuj Kumar, et al.
Publicado: (2018)

Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan
por: Seydoux, Claire, et al.
Publicado: (2023)

Relative Copy Number Variations of CYP2C19 in South Indian Population
por: Devendran, Anichavezhi, et al.
Publicado: (2012)

Role of Drug Transporters in Elucidating Inter-Individual Variability in Pediatric Chemotherapy-Related Toxicities and Response
por: Kamath, Ashwin, et al.
Publicado: (2022)

Pharmacokinetics-adapted Busulfan-based myeloablative conditioning before unrelated umbilical cord blood transplantation for myeloid malignancies in children
por: Benadiba, Joy, et al.
Publicado: (2018)

Commentary: A Myriad Aberrations on Information of Ontogeny of Drug Metabolizing Enzymes in the Pediatric Population: An Obstacle for Personalizing Drug Therapy in the Pediatric Population
por: Uppugunduri, Chakradhara Rao S., et al.
Publicado: (2016)

A novel integrative multi-omics approach to unravel the genetic determinants of rare diseases with application in sinusoidal obstruction syndrome
por: Waespe, Nicolas, et al.
Publicado: (2023)

Validation of SYBR Green based quantification assay for the detection of human Torque Teno virus titers from plasma
por: Tyagi, Anuj Kumar, et al.
Publicado: (2013)

A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations
por: Atilla, Erden, et al.
Publicado: (2017)

Opposite Effects of GSTM1 – and GSTT1 – Gene Deletion Variants on Bone Mineral Density
por: Mlakar, Simona Jurkovic, et al.
Publicado: (2011)

Evaluation of Pupillometry for CYP2D6 Phenotyping in Children Treated with Tramadol
por: Rodieux, Frédérique, et al.
Publicado: (2023)

Polymorphisms of CYP1A1 and GSTM1 Genes and Susceptibility to Oral Cancer
por: Cha, In-Ho, et al.
Publicado: (2007)

The effects of myeloablative or non-myeloablative total body irradiations on intestinal tract in mice
por: Zhu, Shengyun, et al.
Publicado: (2021)

High-dose acyclovir and pre-emptive ganciclovir to prevent cytomegalovirus disease in myeloablative and non-myeloablative allogeneic stem cell transplantation
por: Nakamura, R, et al.
Publicado: (2002)

The analysis of GSTA1 promoter genetic and functional diversity of human populations
por: Mlakar, Vid, et al.
Publicado: (2021)

Polymorphisms in GSTM1, GSTT1 and CYP1A1 and risk of pancreatic adenocarcinoma
por: Liu, G, et al.
Publicado: (2000)

Correction: The effects of myeloablative or non-myeloablative total body irradiations on intestinal tract in mice
Publicado: (2022)

Polymorphisms in the CYP2E1 and GSTM1 Genes as Possible Protection Factors for Leprosy Patients
por: Pinto, Pablo, et al.
Publicado: (2012)

Conversion from twice- to once-daily tacrolimus in pediatric kidney recipients: a pharmacokinetic and bioequivalence study
por: Lapeyraque, Anne-Laure, et al.
Publicado: (2014)

Pediatric Therapeutic Drug Monitoring for Selective Serotonin Reuptake Inhibitors
por: Strawn, Jeffrey R., et al.
Publicado: (2021)

Prioritization of microRNA biomarkers for a prospective evaluation in a cohort of myocardial infarction patients based on their mechanistic role using public datasets
por: Venugopal, Priyanka, et al.
Publicado: (2022)

Association of CYP1A1 and GSTM1 Polymorphisms With Oral Cancer Susceptibility: A Meta-Analysis
por: Liu, Haitao, et al.
Publicado: (2015)

Tissue Damage Caused by Myeloablative, but Not Non-Myeloablative, Conditioning before Allogeneic Stem Cell Transplantation Results in Dermal Macrophage Recruitment without Active T-Cell Interaction
por: van Balen, Peter, et al.
Publicado: (2018)

Immunological Basis of Bone Marrow Failure after Allogeneic Hematopoietic Stem Cell Transplantation
por: Masouridi-Levrat, Stavroula, et al.
Publicado: (2016)

Impact of Pre-Transplant Anti-T Cell Globulin (ATG) on Immune Recovery after Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
por: Servais, Sophie, et al.
Publicado: (2015)

An association between BPDE-like DNA adduct levels and CYP1A1 and GSTM1 polymorphisma in pterygium
por: Tung, Jai-Nien, et al.
Publicado: (2010)

Polymorphisms of GSTM1, GSTT1, GSTP1 and CYP1A1 genes and susceptibility to lung cancer
por: Mota, Paula, et al.
Publicado: (2010)

GSTM1 copy number variation in the context of single nucleotide polymorphisms in the human GSTM cluster
por: Khrunin, Andrey V., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4apbal7qcvk68qj0fe480f0hin